Education
About Us
Working with TipRanks
Follow Us
Thomas Mccourt Insider Profile
4 Followers
Thomas Mccourt, CEO, Director at Ironwood Pharma, holds 1.69M shares in Ironwood Pharma (Ticker: IRWD), holds 0.00 shares in Acceleron Pharma (Ticker: XLRN), holds ― shares in Pliant Therapeutics (Ticker: PLRX).
Profitable Transactions
5 out of 7 Profitable Transactions
Average Return
+40.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Thomas Mccourt holds in companies
Most Profitable Insider Trade
The most profitable trade made by Thomas Mccourt
Thomas Mccourt's Trading History
Ironwood Pharma
May 20, 2025
CEO, Director
Uninformative Buy
―
$1.30M
Acceleron Pharma
Nov 22, 2021
―
Uninformative Sell
―
$0.00
Pliant Therapeutics
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Thomas Mccourt's performance on stock
You May Also Like
Thomas Mccourt insider profile FAQ
What is the percentage of profitable transactions made by Thomas Mccourt?
The percentage of profitable transactions made by Thomas Mccourt is 71%.
What is the average return per transaction made by Thomas Mccourt?
The average return per transaction made by Thomas Mccourt is 40.30%.
What stocks does Thomas Mccourt hold?
Thomas Mccourt holds: IRWD, XLRN, PLRX stocks.
What was Thomas Mccourt’s latest transaction?
Thomas Mccourt latest transaction was an Uninformative Buy of ―.
What was Thomas Mccourt's most profitable transaction?
Thomas Mccourt’s most profitable transaction was an Informative Sell of IRWD stock on May 22, 2024. The return on the trade was 90.40%.
What is Thomas Mccourt's role in Ironwood Pharma?
Thomas Mccourt's role in Ironwood Pharma is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.